Lallemand invests in Turkish enzyme company to boost global reach

Lallemand Inc, a global leader in yeast and bacteria, has announced a strategic investment in Livzym Biotechnologies, a Turkish enzyme manufacturer. The collaboration aims to expand Lallemand's enzyme portfolio and strengthen its position in the global market.

Livzym, founded nine years ago, has developed a robust range of enzymes primarily for the food and animal feed industries, utilizing a cutting-edge fungi-based technology platform. The company's recently operational enzyme plant in Tuzla, Turkey, boasts state-of-the-art production capabilities.

Lallemand's investment, coupled with additional funding from Turkish investors, will fuel the expansion of Livzym's Tuzla plant to meet increasing enzyme demand. The partnership will also see Lallemand take on the global marketing and distribution of Livzym's enzymes while fostering joint development and production initiatives in Turkey.

Lars Asferg, President of Lallemand Bio-Ingredients, emphasized the strategic fit between the two companies. "This collaboration aligns with our commitment to harnessing biotechnology for addressing global challenges in nutrition, health, and the environment," he said. "Livzym's fungal expertise perfectly complements our existing yeast-based enzyme technology, allowing us to offer a wider range of high-performance solutions to our customers."

Dr Serdar Uysal, Founder & CEO of Livzym, highlighted the importance of biotechnology in shaping the future of food and agriculture. "We are excited to partner with Lallemand, a global fermentation leader, to advance sustainable enzyme and alternative protein technologies," he said. "Our collaboration will enable us to expand our reach and impact on a global scale."

The partnership between Lallemand and Livzym marks a significant step forward in the enzyme industry, with the potential to drive innovation and sustainability in food production and other sectors.